EX-32.1 4 a2016q1exhibit321.htm EXHIBIT 32.1 SEC Exhibit


EXHIBIT 32.1
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ARIAD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the period ended March 31, 2016 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated: May 10, 2016
 
 
 
/s/ Paris Panayiotopoulos
 
 
 
 
Paris Panayiotopoulos
 
 
 
 
Chief Executive Officer and President
 
 
 
Dated: May 10, 2016
 
 
 
/s/ Manmeet S. Soni
 
 
 
 
Manmeet S. Soni
 
 
 
 
Executive Vice President,
 
 
 
 
Chief Financial Officer and Treasurer